CARTESIAN THERAPEUTICS INC (RNAC)

US8162123025 - Common Stock

28.26  +3.69 (+15.02%)

After market: 28.26 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
26.00M110.78M85.08M16.60M6.68M
Operating Expenses
111.72M96.24M89.67M73.42M59.13M
Research and Development
71.24M72.38M68.74M54.51M42.74M
Selling, General, and Administrative Expenses
40.48M23.86M20.94M18.91M16.39M
Operating Income
-85.72M14.54M-4.60M-56.82M-52.46M
Interest Income/Expense
-147.43M-980.00K-2.80M-1.24M-730.00K
Other Income/Expense
-4.86M21.21M-2.32M-10.35M-2.16M
Non Recurring Items
-700.00K0.000.00-460.00K0.00
Income Before Taxes
-238.71M34.77M-9.72M-68.88M-55.35M
Income Tax
-19.00M-609.00K15.97MN/AN/A
Net Income
-219.71M35.38M-25.69M-68.88M-55.35M
EBITDA
-84.87M15.82M-3.35M-56.09M-51.73M
 
Per Share Data
EPS Diluted Total Ops
-42.507.28-6.74-0.68-1.22
Non GAAP EPS
-6.140.28-0.31-0.69-1.24
 
Statistics
Profit Margin
-844.91%31.94%-30.19%-414.94%-828.59%
Operating Profit Margin
-329.63%13.12%-5.40%-342.29%-785.33%

All data in USD

Charts